- Melamed, Ze’ev;
- López-Erauskin, Jone;
- Baughn, Michael W;
- Zhang, Ouyang;
- Drenner, Kevin;
- Sun, Ying;
- Freyermuth, Fernande;
- McMahon, Moira A;
- Beccari, Melinda S;
- Artates, Jon W;
- Ohkubo, Takuya;
- Rodriguez, Maria;
- Lin, Nianwei;
- Wu, Dongmei;
- Bennett, C Frank;
- Rigo, Frank;
- Da Cruz, Sandrine;
- Ravits, John;
- Lagier-Tourenne, Clotilde;
- Cleveland, Don W
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are associated with loss of nuclear transactive response DNA-binding protein 43 (TDP-43). Here we identify that TDP-43 regulates expression of the neuronal growth-associated factor stathmin-2. Lowered TDP-43 levels, which reduce its binding to sites within the first intron of stathmin-2 pre-messenger RNA, uncover a cryptic polyadenylation site whose utilization produces a truncated, non-functional mRNA. Reduced stathmin-2 expression is found in neurons trans-differentiated from patient fibroblasts expressing an ALS-causing TDP-43 mutation, in motor cortex and spinal motor neurons from patients with sporadic ALS and familial ALS with GGGGCC repeat expansion in the C9orf72 gene, and in induced pluripotent stem cell (iPSC)-derived motor neurons depleted of TDP-43. Remarkably, while reduction in TDP-43 is shown to inhibit axonal regeneration of iPSC-derived motor neurons, rescue of stathmin-2 expression restores axonal regenerative capacity. Thus, premature polyadenylation-mediated reduction in stathmin-2 is a hallmark of ALS-FTD that functionally links reduced nuclear TDP-43 function to enhanced neuronal vulnerability.